Fluidform Bio, Inc.
Waltham, MA Doing business as Fluidform Inc.
- UEI
- KGL7K51B52Y5
- CAGE
- 8FVL4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 852 Winter St Suite 175, Waltham, MA 02451, USA
- Website
- fluidformbio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Bioprinted human ventricles for in vitro modeling of cardiac arrhythmias - over the past 40 years nearly 45% of drugs… | National Heart Lung and Blood Institute | $685,650 | |
| Sbir phase i: additive manufacturing of silicone elastomers and thermosets using freeform reversible embedding | Division of Industrial Innovation | $249,644 | |
| Advanced manufacturing of a bioprosthetic collagen heart valve - cardiovascular disease is a leading cause of death in… | National Heart Lung and Blood Institute | $766,107 |
About Fluidform Bio, Inc.
Fluidform Inc. is a manufacturer of goods focused on expanding 3D printing capabilities for functional human tissue, silicone elastomers, and thermosetting polymers. They have developed a novel additive manufacturing process called freeform reversible embedding of suspended hydrogels (FRESH) 3D printing.
Fluidform has received federal grants to use the FRESH technique to bioprint human ventricles for modeling cardiac arrhythmias, improve the durability and non-thrombogenic properties of bioprosthetic heart valves through recreating native collagen fiber architecture, and advance additive manufacturing methods for silicone and thermosetting polymers. These projects were funded by the National Institutes of Health's National Heart, Lung and Blood Institute through the Cardiovascular Diseases Research program and the National Science Foundation's Engineering program. Fluidform partners with Carnegie Mellon University on bioprinting research and development and received a sub award from the University of Pittsburgh to work on a regenerative electronic platform.
Quick answers
What is Fluidform Bio, Inc.'s UEI?
Fluidform Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is KGL7K51B52Y5.
What is Fluidform Bio, Inc.'s CAGE code?
Fluidform Bio, Inc.'s CAGE code is 8FVL4.
What is Fluidform Bio, Inc.'s primary NAICS code?
Fluidform Bio, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Fluidform Bio, Inc. located?
Fluidform Bio, Inc.'s physical address in SAM.gov is 852 Winter St Suite 175, Waltham, MA 02451, USA.
Is Fluidform Bio, Inc. registered in SAM.gov?
Yes. Fluidform Bio, Inc.'s SAM.gov registration is active through July 13, 2027.
What is Fluidform Bio, Inc.'s most recent federal award?
Fluidform Bio, Inc.'s most recent federal grant award is Bioprinted human ventricles for in vitro modeling of cardiac arrhythmias - over the past 40 years nearly 45% of drugs… (R43HL160407), from National Heart Lung and Blood Institute, on August 15, 2021.
On GovTribe
See Fluidform Bio, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors